Major Investment Launches Precision Health Platform in Western Sweden to Accelerate Personalised Medicine
核心洞察
The Precision Platform, led by Sahlgrenska University Hospital (搜索) with academic and industry partners, aims to shorten the path from research to clinical implementation in precision health.
A Health Data Sandbox will be established as a secure environment for developing AI-based clinical decision support systems, diagnostic tools, and data-driven solutions.
A pre-GMP laboratory will strengthen the region's capacity to develop and scale up advanced therapy medicinal products (ATMPs) from early innovation to clinical application.
Western Sweden is poised to become a leading European hub for precision health with the launch of the Precision Platform, a major collaborative initiative designed to accelerate the translation of research breakthroughs into clinical practice. Led by Sahlgrenska University Hospital (搜索) in partnership with the University of Gothenburg, Chalmers University of Technology (搜索), and Sahlgrenska Science Park (搜索), the platform represents a key step in delivering the region's Agenda for Life Science.
The Precision Platform is conceived as a single point of access to expertise, research environments, clinical settings, testbeds, infrastructure, and collaboration partners. Its core purpose is to shorten the path from research and innovation to practical implementation in healthcare, recognising that many of the most significant breakthroughs occur at the intersection of different research disciplines, technologies, and clinical specialties.
"We are facing one of the greatest technological advances in healthcare since the emergence of modern medicine. It paves the way for more preventive, precise and personalised healthcare," said Boubou Hallberg, CEO of Sahlgrenska University Hospital (搜索). "To ensure that these new opportunities benefit patients and the wider population, we need environments where research, healthcare and industry can develop new knowledge and solutions together. That is exactly the role the Precision Platform is designed to play."
Strategic Infrastructure Investments
As part of the initiative, two strategic resources for research and innovation will be established. The first is a Health Data Sandbox, a secure testing and computing environment where researchers, companies, and healthcare professionals can develop and evaluate AI-based clinical decision support systems, diagnostic tools, and other data-driven solutions.
The second is a pre-GMP laboratory that will strengthen the region's capacity to develop and scale up advanced therapies, enabling a faster journey from early-stage innovation to clinical application and commercialisation. This facility is particularly significant for the continued development of advanced therapy medicinal products (ATMPs), building on Western Sweden's existing ecosystem in advanced therapies, health data, AI, and precision medicine.
A Collaborative Ecosystem
The initiative brings together complementary strengths from across the region. Martin Nilsson Jacobi, President and CEO of Chalmers University of Technology (搜索), emphasised the university's role: "Precision health is a key area for Chalmers, where we combine strong expertise at the intersection of technology and life science. With the Precision Platform we are taking an important step forward together with our partners in the field, creating strong environments, for example through open testbeds provided by Chalmers Next Labs."
Jenny Nyström, Professor and Dean of the Sahlgrenska Academy at the University of Gothenburg, highlighted the platform's importance for ATMP development, noting it will give "researchers, students and collaborative partners better opportunities to develop, test and bring new medical innovations into healthcare."
The platform also incorporates a person-centred care dimension. Axel Wolf, Professor and Director of the University of Gothenburg Centre for Person-centred Care, stated: "Western Sweden has a unique combination of expertise that also includes person-centred care and patient involvement. This creates the conditions to develop solutions that are medically accurate, organisationally sustainable and socioeconomically valuable."
Accelerating Innovation to Market
Sahlgrenska Science Park (搜索) will serve as a catalyst within the ecosystem. Cecilia Edebo, CEO of Sahlgrenska Science Park, explained: "To accelerate innovation, we must translate research and technological breakthroughs into real-world impact much faster. Sahlgrenska Science Park acts as a catalyst by making it easier for our many start-ups and industry partners to connect with researchers, healthcare providers and test environments through the Precision Platform."
The overall ambition is to establish Western Sweden as a leading innovation hub for precision health, creating an environment where researchers, healthcare providers, companies, and innovation actors can develop, test, and implement next-generation solutions for prevention, diagnostics, and treatment.
Helena Lundberg Nilsson, Regional Director of Development for Region Västra Götaland, underscored the strategic importance: "Western Sweden is well positioned to take a leading role in the development of precision health. Through the Precision Platform, we are strengthening the region's attractiveness for investment, research excellence and innovative companies, while reinforcing our position as a leading life science region."
The initiative is expected to strengthen conditions for new collaborations in research, development, and innovation while making Western Sweden more attractive to talent, investment, and international partnerships. In the long term, it aims to improve population health and position Western Sweden as one of Europe's leading ecosystems for precision health.